Quick Answer
Wellgistics Health, Inc. reported Total Revenue of $23.34 million for fiscal year 2025.
Wellgistics Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $23.34M +28.7% |
$18.13M | — | — |
| Revenue (ASC 606) | $23.34M +28.7% |
$18.13M | — | — |
| Net Income | -$101.27M -1377.1% |
-$6.86M -136.8% |
-$2.90M | — |
| Diluted EPS | -$1.43 -853.3% |
-$0.15 -150.0% |
-$0.06 | — |
| Total Assets | $30.46M -46.9% |
$57.33M +16844.1% |
$338.4K | — |
| Cash and Equivalents | $42.6K -95.9% |
$1.03M +75291.2% |
$1.4K | — |
| Stockholders Equity | -$12.45M -284.8% |
$6.73M +332.2% |
-$2.90M -55146.4% |
-$5.2K |
| Operating Income | -$93.75M -1425.6% |
-$6.15M -113.3% |
-$2.88M | — |
| Gross Profit | -$6.43M -463.6% |
$1.77M | — | — |
| Shares Outstanding | 101.31M +98.4% |
51.06M +14.2% |
44.72M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $3.01M | -46.9% | -61.3% |
| Revenue (ASC 606) | September 30, 2025 | $3.01M | -46.9% | -61.3% |
| Net Income | September 30, 2025 | -$34.32M | -1738.1% | -414.3% |
| Diluted EPS | September 30, 2025 | -$0.46 | -1050.0% | -318.2% |
| Total Assets | September 30, 2025 | $52.78M | — | -2.7% |
| Cash and Equivalents | September 30, 2025 | $4.23M | — | +907.0% |
| Stockholders Equity | September 30, 2025 | $6.78M | -32.1% | +648.7% |
| Operating Income | September 30, 2025 | -$31.55M | -1708.1% | -473.6% |
| Gross Profit | September 30, 2025 | $231.0K | -55.7% | -54.3% |
| Shares Outstanding | September 30, 2025 | 89.45M | — | +41.7% |
- Wellgistics Health, Inc. reported Total Revenue of $23.34 million for fiscal year 2025.
- Wellgistics Health, Inc. showed an increase of +28.7% in Total Revenue compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Revenue (ASC 606) of $23.34 million for fiscal year 2025.
- Wellgistics Health, Inc. showed an increase of +28.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Net Income of -$101.27 million for fiscal year 2025.
- Wellgistics Health, Inc. showed a decrease of -1377.1% in Net Income compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Diluted EPS of $1.43 per share (loss) for fiscal year 2025.
- Wellgistics Health, Inc. showed a decrease of -853.3% in Diluted EPS compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Total Assets of $30.46 million for fiscal year 2025.
- Wellgistics Health, Inc. showed a decrease of -46.9% in Total Assets compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Cash and Equivalents of $42.6 thousand for fiscal year 2025.
- Wellgistics Health, Inc. showed a decrease of -95.9% in Cash and Equivalents compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Stockholders Equity of -$12.45 million for fiscal year 2025.
- Wellgistics Health, Inc. showed a decrease of -284.8% in Stockholders Equity compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Operating Income of -$93.75 million for fiscal year 2025.
- Wellgistics Health, Inc. showed a decrease of -1425.6% in Operating Income compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Gross Profit of -$6.43 million for fiscal year 2025.
- Wellgistics Health, Inc. showed a decrease of -463.6% in Gross Profit compared to the prior fiscal year.
- Wellgistics Health, Inc. reported Shares Outstanding of 101.31 million shares for fiscal year 2025.
- Wellgistics Health, Inc. showed an increase of +98.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: